PT - JOURNAL ARTICLE AU - Elisabeth Rounis AU - Ajay Halai AU - Gloria Pizzamiglio AU - Matthew A. Lambon Ralph TI - Characterising factors underlying praxis deficits in chronic left hemisphere stroke patients AID - 10.1101/2020.10.16.20213744 DP - 2020 Jan 01 TA - medRxiv PG - 2020.10.16.20213744 4099 - http://medrxiv.org/content/early/2020/10/20/2020.10.16.20213744.short 4100 - http://medrxiv.org/content/early/2020/10/20/2020.10.16.20213744.full AB - Limb apraxia, a disorder of skilled action not consequent on primary motor or sensory deficits, has traditionally been defined according to errors patients make on neuropsychological tasks. Previous models of the disorder have failed to provide a unified account of patients’ deficits, due to heterogeneity in the patients and tasks used. In this study we implemented principal component analysis (PCA) to elucidate core factors of the disorder in a cohort of 41 unselected left hemisphere chronic stroke patients who were tested on a comprehensive and validated apraxia screen. Three principal components were identified: posture selection, semantic control and multi-demand sequencing. These were submitted to a lesion symptom mapping (VBCM) analysis in a subset of 24 patients, controlled for lesion volume, age and time post-stroke. Although the first component revealed no significant structural correlates, the second and third components were related to regions in the ‘ventro-dorsal’ and ‘ventral’ and ‘dorsal’ pathways, respectively. These results challenge the previously reported distinction between ideomotor and ideational deficits and highlight a significant role of common cognitive functions in the disorder, which include action selection, semantic retrieval, sequencing and response inhibition. Further research using this technique would help elucidate the cognitive processes underlying limb apraxia and their relationship with other cognitive disorders.Competing Interest StatementThe authors have declared no competing interest.Funding StatementHelen Dawson grant from the British Medical Association, as well as grants from the Oxford University Clinical Academic Graduate School and Oxfordshire Health Services Research Committee to Dr Rounis. Dr Halai and Professor Lambon Ralph were supported by The Rosetrees Trust (no. A1699 to Dr Halai and Professor Lambon Ralph), the ERC (GAP: 670428, BRAIN2MIND_NEURO_COMP to Professor Lambon Ralph) and MRC intramural funding (MC_UU_00005/18).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Health Research Authority, South Central, Berkshire Ethics committee.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCould be made available anonymised upon request to lead author, depending on research question.